TrialBritish journal of clinical pharmacology2014

Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.

Ana B Santoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.